Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1186/s13148-024-01666-2
Published Online: 2024-04-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cheng, Yuxi
Song, Zhengzheng
Fang, Xiaodan
Tang, Zhangui
Text and Data Mining valid from 2024-04-10
Version of Record valid from 2024-04-10
Article History
Received: 15 December 2023
Accepted: 28 March 2024
First Online: 10 April 2024
Declarations
:
: Not applicable.
: The authors declare no competing financial interest.